Quoin Pharmaceuticals (QNRX) Total Current Liabilities (2017 - 2026)

Quoin Pharmaceuticals has disclosed Total Current Liabilities across 10 years of filings, most recently posting $6.6 million for Q2 2026.

• In Q2 2026, Total Current Liabilities rose 52.46% year-over-year to $6.6 million; the TTM figure through Jun 2026 stood at $6.6 million (up 52.46% YoY), while the FY2025 annual figure was $5.5 million, up 32.67% from the prior year.
• Total Current Liabilities came in at $6.6 million for Q2 2026 at Quoin Pharmaceuticals, up from $5.3 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $6.6 million in Q2 2026 to a low of $3.5 million in Q3 2024.
• Average Total Current Liabilities over 5 years is $4.5 million, with a median of $4.2 million recorded in 2024.
• Year-over-year, Total Current Liabilities slipped 24.16% in 2024 and jumped 65.95% in 2025.
• Over 5 years, Total Current Liabilities stood at $3.5 million in 2022, then advanced by 1.53% to $3.6 million in 2023, then rose by 16.74% to $4.2 million in 2024, then surged by 32.67% to $5.5 million in 2025, then increased by 19.22% to $6.6 million in 2026.
• Per Business Quant data, the three most recent Total Current Liabilities figures were $6.6 million in Q2 2026, $5.3 million in Q1 2026, and $5.5 million in Q4 2025.